QUCY — Quantum Cyber N.V.

Is QUCY overbought or oversold? Here is the current MarketMoodz read.

Healthcare · Diagnostics & Research

Overbought As of August 19, 2026

Quantum Cyber N.V. (QUCY) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Healthcare name (Diagnostics & Research) last closed at $1.43. The rating moved from Oversold to Overbought on August 14, 2026.

See all overbought Healthcare stocks →

AI analysis

Quantum Cyber N.V. is a low-priced, likely thinly traded cybersecurity issuer with limited publicly available financial disclosure. Market conditions over the past hours show a modestly risk-on tone that could support short-term speculative interest, but absence of recent filings, sparse social/research coverage, and typical microcap dynamics (dilution risk, low liquidity) make near-term performance driven more by sentiment than visible operating progress. The cybersecurity sector provides a favorable long-run demand backdrop, but execution, funding, and competitive challenges are material. Given the information gap, investors should prioritize obtaining up-to-date financials, management commentary, and liquidity metrics before increasing exposure; scenarios range from idiosyncratic upside on positive contract/technical news to steep downside on dilution or weak operating results.

Key factors

  • Current public information on Quantum Cyber N.V. is limited, constraining detailed financial visibility
  • Microcap price level and likely low free float/liquidity increase volatility and bid-ask spreads
  • Cybersecurity market fundamentals remain favorable over the medium term due to persistent enterprise security demand
  • Macro environment: recent mild risk-on tone and rotation into growth could support speculative growth names in the short term
  • No recent company-specific EDGAR/filings or social sentiment data available to validate revenue, profitability, or contracts
  • Potential for near-term price moves driven more by sentiment and newsflow than by observable operating performance

Risks

  • Insufficient public financial disclosure and lack of recent filings increases execution and transparency risk
  • High dilution risk if the company funds operations through equity raises (common for early-stage or microcap issuers)
  • Low liquidity and thin trading could amplify price moves and make exit/entry difficult
  • Intense competition in cybersecurity from well-capitalized incumbents and niche specialists
  • Macro shocks (rate volatility, risk-off moves) could rapidly hit speculative microcap valuations
  • Operational risk from failure to commercialize products or secure key contracts; regulatory or geopolitical developments could also impact business

See today's live rating, score and targets

Members see the live hourly rating for QUCY — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.